BridgePort Financial Solutions LLC Has $521,000 Stock Position in UnitedHealth Group Incorporated $UNH

BridgePort Financial Solutions LLC raised its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 8.7% during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 1,669 shares of the healthcare conglomerate’s stock after buying an additional 133 shares during the quarter. BridgePort Financial Solutions LLC’s holdings in UnitedHealth Group were worth $521,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. Vanguard Group Inc. lifted its position in shares of UnitedHealth Group by 6.6% in the 1st quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate’s stock worth $47,519,620,000 after acquiring an additional 5,583,343 shares during the period. Wellington Management Group LLP lifted its position in shares of UnitedHealth Group by 10.6% in the 1st quarter. Wellington Management Group LLP now owns 25,847,940 shares of the healthcare conglomerate’s stock worth $13,537,859,000 after acquiring an additional 2,486,839 shares during the period. Bank of New York Mellon Corp lifted its position in shares of UnitedHealth Group by 2.5% in the 1st quarter. Bank of New York Mellon Corp now owns 8,128,174 shares of the healthcare conglomerate’s stock worth $4,257,131,000 after acquiring an additional 196,696 shares during the period. Nuveen LLC bought a new stake in shares of UnitedHealth Group in the 1st quarter worth approximately $3,846,764,000. Finally, Charles Schwab Investment Management Inc. lifted its position in shares of UnitedHealth Group by 13.6% in the 1st quarter. Charles Schwab Investment Management Inc. now owns 7,070,385 shares of the healthcare conglomerate’s stock worth $3,702,736,000 after acquiring an additional 847,054 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Trading Up 1.8%

UNH stock opened at $360.17 on Friday. The business has a fifty day moving average of $307.84 and a 200-day moving average of $354.55. The company has a market cap of $326.20 billion, a P/E ratio of 15.61, a PEG ratio of 2.34 and a beta of 0.47. UnitedHealth Group Incorporated has a twelve month low of $234.60 and a twelve month high of $630.73. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.45 by ($0.37). The firm had revenue of $111.62 billion during the quarter, compared to the consensus estimate of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. UnitedHealth Group’s revenue was up 12.9% on a year-over-year basis. During the same quarter in the prior year, the business earned $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, equities research analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, September 23rd. Investors of record on Monday, September 15th were issued a $2.21 dividend. The ex-dividend date was Monday, September 15th. This represents a $8.84 annualized dividend and a yield of 2.5%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 38.30%.

Wall Street Analysts Forecast Growth

Several brokerages recently commented on UNH. Wells Fargo & Company decreased their price target on UnitedHealth Group from $306.00 to $267.00 and set an “overweight” rating on the stock in a research note on Monday, August 4th. Morgan Stanley increased their price objective on UnitedHealth Group from $325.00 to $395.00 and gave the stock an “overweight” rating in a research note on Friday, September 12th. Sanford C. Bernstein increased their price objective on UnitedHealth Group from $337.00 to $379.00 and gave the stock an “outperform” rating in a research note on Friday, September 5th. Oppenheimer dropped their price objective on UnitedHealth Group from $400.00 to $325.00 and set an “outperform” rating for the company in a research note on Wednesday, July 30th. Finally, Cantor Fitzgerald reiterated an “overweight” rating and set a $440.00 price objective on shares of UnitedHealth Group in a research note on Tuesday, August 26th. Sixteen research analysts have rated the stock with a Buy rating, six have issued a Hold rating and four have issued a Sell rating to the company. According to MarketBeat.com, UnitedHealth Group presently has a consensus rating of “Hold” and a consensus price target of $358.95.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.